Multiple Sclerosis

February 1998, Volume 4, Issue 1
Table of Contents

Journal Home
<- Previous Journal Contents Next ->

Cerebrospinal fluid markers in multiple sclerosis: an overview 1
AR Massaro & P Tonali
Abstract    Full Article (PDF)

Protein markers of brain damage 5
EJ Thompson & AJE Green
Abstract    Full Article (PDF)

Multiple Sclerosis: IL-2 and sIL-2R levels in cerebrospinal fluid and serum. Review of literature and critical analysis of ELISA pitfalls 7
S Sivieri, AM Ferrarini & P Gallo
Abstract    Full Article (PDF)

The cytokine storm in multiple sclerosis 12
Hans Link
Abstract    Full Article (PDF)

Myelin basic protein in cerebrospinal fluid and other body fluids 16
John N Whitaker
Abstract    Full Article (PDF)

Intrathecal synthesis of virus-specific oligoclonal IgG, and of free kappa and free lambda oligoclonal bands in acute monosymptomatic optic neuritis. Comparison with brain MRI 22
Jette L Frederiksen & Christian JM Sindic
Abstract    Full Article (PDF)

Cerebrospinal fluid and serum nitric oxide metabolites in patients with multiple sclerosis 27
G Giovannoni
Abstract    Full Article (PDF)

Identification of peptides binding to IgG in the CSF of Multiple Sclerosis patients 31
I Cortese, S Capone, R Tafi, LME Grimaldi, A Nicosia & R Cortese
Abstract    Full Article (PDF)

Abnormalities of biogenic amines affecting the metabolism of serotonin and catecholamines 37
Karel JB Lamers & Ron A Wevers
Abstract    Full Article (PDF)

Soluble Intercellular Adhesion Molecule-1 (sICAM-1) in serum and cerebrospinal fluid of demyelinating diseases of the central and peripheral nervous system 39
M Trojano, C Avolio, M Ruggieri, F De Robertis, F Giuliani, D Paolicelli & P Livrea
Abstract    Full Article (PDF)


© Macmillan Publishers Ltd 1998

As part of one of the world's largest publishers, Stockton Press has a substantial list of leading international journals in the key areas of science and medicine. Specialist fields covered include: bone marrow transplantation, cell death and differentiation, critical care/intensive care, dentistry, dentomaxillofacial radiology, gene therapy, haematology, human and experimental toxicology, human hypertension, impotence research, industrial microbiology, information systems, leukemia, lupus, molecular psychiatry, multiple sclerosis, neuroscience, nursing, nutrition, obesity, oncology, operations research, optometry and ophthalmology, oral diseases, orthopaedics, paraplegia, pharmacology, psychiatry, public health, spinal injury and disease.